Fibrinogen Aα gene genotyping in patients with inherited afibrinogenemia deficiency; a novel mutation in Iranian afibrinogenemia patients

被引:0
作者
Moazzeni, Ali [1 ]
Naderi, Majid [2 ]
Dorgalaleh, Akbar [3 ]
Alizadeh, Shaban [1 ,4 ]
机构
[1] Univ Tehran Med Sci, Allied Med Sch, Hematol Dept, Tehran, Iran
[2] Zahedan Univ Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran
[3] Iran Univ Med Sci, Sch Allied Med, Dept Hematol & Blood Transfus, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Allied Med Sci, Hematol Hematol & Transfus Sci Dept, Tehran 14177, Iran
关键词
A alpha chain of fibrinogen; afibrinogenemia; congenital fibrinogen deficiency; rare bleeding disorders; RARE BLEEDING DISORDERS; CLINICAL PRESENTATIONS; IDENTIFICATION; EPIDEMIOLOGY; DIAGNOSIS; SEVERITY;
D O I
10.1097/MBC.0000000000001260
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Congenital fibrinogen deficiencies (CFD) are a group of rare bleeding disorders (RBD). Afibrinogenemia as a subclass of these disorders would occurs as a result of mutations in fibrinogen gene. Here in, the sequences of A alpha chain of fibrinogen (FGA) in patients with inherited afibrinogenemia disorder in south-eastern of Iran were analysed.Methods The FGA gene exons were amplified using PCR method and the DNA sequences were analysed to study the mutations in A alpha chain of Fibrinogen.Results Results showed that there was no large deletion in FGA gene. Although a frame shift mutation: c.196_197insT p.Ser66PhefsX10 in a patient and a novel mutation of IVS2-1G>A in two other patients were detected which were different from those detected in European population.Conclusion Different mutations are responsible of afibrinogenemia deficiency which requires more relevant studies for confirmation. The type and distribution of mutations in fibrinogen gene in Iranian patients is significantly different with reported mutations in European patients.
引用
收藏
页码:517 / 522
页数:6
相关论文
共 25 条
  • [1] Rare inherited disorders of fibrinogen
    Acharya, S. S.
    Dimichele, D. M.
    [J]. HAEMOPHILIA, 2008, 14 (06) : 1151 - 1158
  • [2] The molecular basis of quantitative fibrinogen disorders
    Asselta, R.
    Duga, S.
    Tenchini, M. L.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (10) : 2115 - 2129
  • [3] Asselta R, 2002, HAEMATOLOGICA, V87, P855
  • [4] Fibrinogen replacement therapy for congenital fibrinogen deficiency
    Bornikova, L.
    Peyvandi, F.
    Allen, G.
    Bernstein, J.
    Manco-Johnson, M. J.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (09) : 1687 - 1704
  • [5] Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management
    Casini, Alessandro
    Neerman-Arbez, Marguerite
    de Moerloose, Philippe
    [J]. BLOOD REVIEWS, 2021, 48
  • [6] Congenital Fibrinogen Disorders
    de Moerloose, Philippe
    Neerman-Arbez, Marguerite
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2009, 35 (04) : 356 - 366
  • [7] Dual function for U2AF35 in AG-dependent pre-mRNA splicing
    Guth, S
    Tange, TO
    Kellenberger, E
    Valcárcel, J
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (22) : 7673 - 7681
  • [8] New insights into the expression and role of platelet factor XIII-A
    Jayo, A.
    Conde, I.
    Lastres, P.
    Jimenez-Yuste, V.
    Gonzalez-Manchon, C.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (07) : 1184 - 1191
  • [9] Biased exon/intron distribution of cryptic and de novo 3′ splice sites
    Královicová, J
    Christensen, MB
    Vorechovsky, I
    [J]. NUCLEIC ACIDS RESEARCH, 2005, 33 (15) : 4882 - 4898
  • [10] Naderi M, 2014, J PEDIAT REV, V2, P31